Shawn Cross, Chief Financial Officer at Pacira BioSciences, Inc. (PCRX), sold 12,059 shares at $25.14 ($303K) on 2026-04-20, disclosed to the SEC on 2026-04-22.
Scheduled sale ($303k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.14 | 7,714 | $194K | 64.1% |
| 2 | $25.01 | 2,845 | $71K | 23.5% |
| 3 | $25.01 | 1,500 | $38K | 12.4% |
| Total | $25.09 avg | 12,059 | $303K | 100% |
| Filing → |
| PCRX | SELL | 2025-11-13 | $533K | — | Filing → |
| AMTI | SELL | 2023-11-24 | $18K | — | Filing → |
| AMTI | SELL | 2023-11-16 | $14K | — | Filing → |